Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis

World Journal of Gastroenterology

Volumn 20, Issue 28, 2014, Pages 9458-9467

  Da Silva, Bruno César ^a   Lyra, Andre Castro ^a,b   Rocha, Raquel ^a   Santana, Genoile Oliveira ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b HOSPITAL SÃO RAFAEL   (Brazil)

Author keywords

Incidence; Predictive factors; Prevalence; Risk factors; Ulcerative colitis

Indexed keywords

MARKER; NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

AGE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE SEVERITY; ENTEROPATHY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENDER; HUMAN; INCIDENCE; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; OBESITY; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; SEROLOGY; ULCERATIVE COLITIS; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; COLITIS, ULCERATIVE; MIDDLE AGED; MORTALITY; ONSET AGE; PHENOTYPE; PREDICTIVE VALUE; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; COLITIS, ULCERATIVE; HUMANS; INCIDENCE; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84908876257     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i28.9458     Document Type: Review

References (116)

1. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105: 501-523; quiz 524 [PMID: 20068560 DOI: 10.1038/ajg.2009.727]
2. Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517 [PMID: 15168363]
3. Molinié F, Gower-Rousseau C, Yzet T, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL, Colombel JF, Salomez JL, Cortot A. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 2004; 53: 843-848 [PMID: 15138211]
4. Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 2006; 12: 6102-6108 [PMID: 17036379]
5. Appleyard CB, Hernández G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis 2004; 10: 106-111 [PMID: 15168809]
6. Yang SK, Hong WS, Min YI, Kim HY, Yoo JY, Rhee PL, Rhee JC, Chang DK, Song IS, Jung SA, Park EB, Yoo HM, Lee DK, Kim YK. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol 2000; 15: 1037-1042 [PMID: 11059934]
7. Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, Lakatos PL. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol 2004; 10: 404-409 [PMID: 14760767]
8. Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 2013; 29: 357-362 [PMID: 23695429 DOI: 10.1097/MOG.0b013e32836229fb]
9. Niriella MA, De Silva AP, Dayaratne AH, Ariyasinghe MH, Navarathne MM, Peiris RS, Samarasekara DN, Satharasinghe RL, Rajindrajith S, Dassanayake AS, Wickramasinghe AR, de Silva HJ. Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey. BMC Gastroenterol 2010; 10: 32 [PMID: 20302651 DOI: 10.1186/1471-230X-10-32]
10. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn' s disease in Japan. J Gastroenterol 2009; 44: 659-665 [PMID: 19424654 DOI: 10.1007/s00535-009-0057-3]
11. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794 [PMID: 21530745 DOI: 10.1053/j.gastro.2011.01.055]
12. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-697 [PMID: 9014768]
13. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991; 100: 143-149 [PMID: 1983816]
14. Victoria CR, Sassak LY, Nunes HR. Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arq Gastroenterol 2009; 46: 20-25 [PMID: 19466305]
15. Evans JG. Trends in mortality from ulcerative colitis in England and Wales. Gut 1971; 12: 119-122 [PMID: 5548556]
16. Gyde S, Prior P, Dew MJ, Saunders V, Waterhouse JA, Allan RN. Mortality in ulcerative colitis. Gastroenterology 1982; 83: 36-43 [PMID: 7075944]
17. Jess T, Gamborg M, Munkholm P, Sørensen TI. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 2007; 102: 609-617 [PMID: 17156150]
18. Manninen P, Karvonen AL, Huhtala H, Rasmussen M, Salo M, Mustaniemi L, Pirttiniemi I, Collin P. Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland. J Crohns Colitis 2012; 6: 524-528 [PMID: 22398058 DOI: 10.1016/j.crohns.2011.10.009]
19. Selinger CP, Andrews J, Dent OF, Norton I, Jones B, McDonald C, Cowlishaw J, Barr G, Selby W, Leong RW. Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2013; 19: 1880-1888 [PMID: 23765177 DOI: 10.1097/MIB.0b013e31829080a8]
20. Jess T, Frisch M, Simonsen J. Trends in overall and causespecific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol 2013; 11: 43-48 [PMID: 23022699 DOI: 10.1016/j.cgh.2012.09.026]
21. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol 2012; 27: 1266-1280 [PMID: 22497584 DOI: 10.1111/j.1440-1746.2012.07150.x]
22. Stowe SP, Redmond SR, Stormont JM, Shah AN, Chessin LN, Segal HL, Chey WY. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 1990; 98: 104-110 [PMID: 2293567]
23. Loftus CG, Loftus EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ, Sandborn WJ. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13: 254-261 [PMID: 17206702]
24. Souza MH, Troncon LE, Rodrigues CM, Viana CF, Onofre PH, Monteiro RA, Passos AD, Martinelli AL, Meneghelli UG. [Trends in the occurrence (1980-1999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in southeastern Brazil]. Arq Gastroenterol 2002; 39: 98-105 [PMID: 12612713]
25. Henderson P, Hansen R, Cameron FL, Gerasimidis K, Rogers P, Bisset WM, Reynish EL, Drummond HE, Anderson NH, Van Limbergen J, Russell RK, Satsangi J, Wilson DC. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis 2012; 18: 999-1005 [PMID: 21688352 DOI: 10.1002/ibd.21797]
26. Pant C, Anderson MP, Deshpande A, Grunow JE, O'Connor JA, Philpott JR, Sferra TJ. Trends in hospitalizations of children with inflammatory bowel disease within the United States from 2000 to 2009. J Investig Med 2013; 61: 1036-1038 [PMID: 23797749 DOI: 10.231/JIM.0b013e31829a4e25]
27. Lindberg E, Lindquist B, Holmquist L, Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Pediatr Gastroenterol Nutr 2000; 30: 259-264 [PMID: 10749408]
28. Bottini N, Gloria-Bottini F, Lucarini N, Ronchetti PG, Fontana L. Inflammatory bowel disease: Are there gender differences in the genetics of signal transduction? A preliminary study of cytosolic low molecular weight protein tyrosine phosphatase. Dis Markers 2000; 16: 163-166 [PMID: 11381200]
29. Teruel M, Martin JE, Gómez-García M, Cardeña C, Rodrigo L, Nieto A, Alcain G, Cueto I, López-Nevot MA, Martin J. Lack of association of ACP1 gene with inflammatory bowel disease: a case-control study. Tissue Antigens 2012; 80: 61-64 [PMID: 22428720 DOI: 10.1111/j.1399-0039.2012.01861.x]
30. Barreiro-de Acosta M, Magro F, Carpio D, Lago P, Echarri A, Cotter J, Pereira S, Gonçalves R, Lorenzo A, Carvalho L, Castro J, Barros L, Dias JA, Rodrigues S, Portela F, Dias C, da Costa-Pereira A. Ulcerative colitis in northern Portugal and Galicia in Spain. Inflamm Bowel Dis 2010; 16: 1227-1238 [PMID: 19924807 DOI: 10.1002/ibd.21170]
31. Betteridge JD, Armbruster SP, Maydonovitch C, Veerappan GR. Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflamm Bowel Dis 2013; 19: 1421-1427 [PMID: 23518811 DOI: 10.1097/MIB.0b013e318281334d]
32. Peeters M, Cortot A, Vermeire S, Colombel JF. Familial and sporadic inflammatory bowel disease: different entities? Inflamm Bowel Dis 2000; 6: 314-320 [PMID: 11149564]
33. Halme L, Turunen U, Heliö T, Paavola P, Walle T, Miettinen A, Järvinen H, Kontula K, Färkkilä M. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol 2002; 37: 692-698 [PMID: 12126248]
34. Henriksen M, Jahnsen J, Lygren I, Vatn MH, Moum B. Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study. Am J Gastroenterol 2007; 102: 1955-1963 [PMID: 17573793]
35. Roma ES, Panayiotou J, Pachoula J, Constantinidou C, Polyzos A, Zellos A, Lagona E, Mantzaris GJ, Syriopoulou VP. Inflammatory bowel disease in children: the role of a positive family history. Eur J Gastroenterol Hepatol 2010; 22: 710-715 [PMID: 19543100 DOI: 10.1097/MEG.0b013e32832e2bd8]
36. Kuwahara E, Asakura K, Nishiwaki Y, Inoue N, Watanabe M, Hibi T, Takebayashi T. Effects of family history on inflammatory bowel disease characteristics in Japanese patients. J Gastroenterol 2012; 47: 961-968 [PMID: 22382632 DOI: 10.1007/s00535-012-0558-3]
37. Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol 2014; 20: 6-21 [PMID: 24415853]
38. Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol 2008; 14: 165-173 [PMID: 18186549]
39. Calkins BM. A meta-analysis of the role of smoking in in-flammatory bowel disease. Dig Dis Sci 1989; 34: 1841-1854 [PMID: 2598752]
40. Odes HS, Fich A, Reif S, Halak A, Lavy A, Keter D, Eliakim R, Paz J, Broide E, Niv Y, Ron Y, Villa Y, Arber N, Gilat T. Effects of current cigarette smoking on clinical course of Crohn' s disease and ulcerative colitis. Dig Dis Sci 2001; 46: 1717-1721 [PMID: 11508673]
41. Aldhous MC, Drummond HE, Anderson N, Baneshi MR, Smith LA, Arnott ID, Satsangi J. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 2007; 102: 589-597 [PMID: 17338737]
42. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004; 18: 481-496 [PMID: 15157822]
43. Velayos FS, Loftus EV, Jess T, Harmsen WS, Bida J, Zinsmeister AR, Tremaine WJ, Sandborn WJ. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology 2006; 130: 1941-1949 [PMID: 16762617]
44. Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE, Korzenik J. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol 2008; 103: 2925-2931 [PMID: 18775018 DOI: 10.1111/j.1572-0241.2008.02118.x]
45. Rutgeerts P, D'Haens G, Hiele M, Geboes K, Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994; 106: 1251-1253 [PMID: 8174886]
46. Matsushita M, Takakuwa H, Matsubayashi Y, Nishio A, Ikehara S, Okazaki K. Appendix is a priming site in the development of ulcerative colitis. World J Gastroenterol 2005; 11: 4869-4874 [PMID: 16097061]
47. Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 2002; 8: 277-286 [PMID: 12131612]
48. Naganuma M, Iizuka B, Torii A, Ogihara T, Kawamura Y, Ichinose M, Kojima Y, Hibi T. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001; 96: 1123-1126 [PMID: 11316158]
49. Radford-Smith GL, Edwards JE, Purdie DM, Pandeya N, Watson M, Martin NG, Green A, Newman B, Florin TH. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002; 51: 808-813 [PMID: 12427781]
50. Florin TH, Pandeya N, Radford-Smith GL. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Gut 2004; 53: 973-979 [PMID: 15194646]
51. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011; 8: 523-531 [PMID: 21844910]
52. Prince A, Whelan K, Moosa A, Lomer MC, Reidlinger DP. Nutritional problems in inflammatory bowel disease: the patient perspective. J Crohns Colitis 2011; 5: 443-450 [PMID: 21939918 DOI: 10.1016/j.crohns.2011.04.016]
53. Lucendo AJ, De Rezende LC. Importance of nutrition in inflammatory bowel disease. World J Gastroenterol 2009; 15: 2081-2088 [PMID: 19418580]
54. Yamamoto T, Nakahigashi M, Saniabadi AR. Review article: diet and inflammatory bowel disease-epidemiology and treatment. Aliment Pharmacol Ther 2009; 30: 99-112 [PMID: 19438426 DOI: 10.1111/j.1365-2036.2009.04035.x]
55. Nguyen GC, Munsell M, Harris ML. Nationwide prevalence and prognostic significance of clinically diagnosable proteincalorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis 2008; 14: 1105-1111 [PMID: 18302272 DOI: 10.1002/ibd.20429]
56. Mijac DD, Janković GL, Jorga J, Krstić MN. Nutritional status in patients with active inflammatory bowel disease: prevalence of malnutrition and methods for routine nutritional assessment. Eur J Intern Med 2010; 21: 315-319 [PMID: 20603043 DOI: 10.1016/j.ejim.2010.04.012]
57. Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis 2013; 7: 107-112 [PMID: 22440891 DOI: 10.1016/j.crohns.2012.02.015]
58. Norman K, Kirchner H, Lochs H, Pirlich M. Malnutrition affects quality of life in gastroenterology patients. World J Gastroenterol 2006; 12: 3380-3385 [PMID: 16733855]
59. Valentini L, Schaper L, Buning C, Hengstermann S, Koernicke T, Tillinger W, Guglielmi FW, Norman K, Buhner S, Ockenga J, Pirlich M, Lochs H. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission. Nutrition 2008; 24: 694-702 [PMID: 18499398 DOI: 10.1016/j.nut.2008.03.018]
60. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol 2003; 98: 1556-1562 [PMID: 12873577]
61. Teixeira LG, Leonel AJ, Aguilar EC, Batista NV, Alves AC, Coimbra CC, Ferreira AV, de Faria AM, Cara DC, Alvarez Leite JI. The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation. Lipids Health Dis 2011; 10: 204 [PMID: 22073943 DOI: 10.1186/1476-511X-10-204]
62. Hill RJ, Davies PS. You look all right to me: compromised nutritional status in paediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013; 56: 385-389 [PMID: 23201705 DOI: 10.1097/MPG.0b013e31827e1f25]
63. Steed H, Walsh S, Reynolds N. A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland. Obes Facts 2009; 2: 370-372 [PMID: 20090388 DOI: 10.1159/000262276]
64. Wibmer AG, Kroesen AJ, Gröne J, Slavova N, Weinhold A, Buhr HJ, Ritz JP. Predictors of permanent ileostomy after restorative proctocolectomy. Br J Surg 2010; 97: 1561-1566 [PMID: 20632324 DOI: 10.1002/bjs.7135]
65. Canedo JA, Pinto RA, McLemore EC, Rosen L, Wexner SD. Restorative proctectomy with ileal pouch-anal anastomosis in obese patients. Dis Colon Rectum 2010; 53: 1030-1034 [PMID: 20551755 DOI: 10.1007/DCR.0b013e3181db7029]
66. Sourianarayanane A, Garg G, Smith TH, Butt MI, McCullough AJ, Shen B. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. J Crohns Colitis 2013; 7: e279-e285 [PMID: 23158500 DOI: 10.1016/j.crohns.2012.10.015]
67. Yuhara H, Steinmaus C, Corley D, Koike J, Igarashi M, Suzuki T, Mine T. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013; 37: 953-962 [PMID: 23550660 DOI: 10.1111/apt.12294]
68. Harper JW, Sinanan MN, Zisman TL. Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 2118-2124 [PMID: 23863401 DOI: 10.1097/MIB.0b013e31829cf401]
69. Markel TA, Lou DC, Pfefferkorn M, Scherer LR, West K, Rouse T, Engum S, Ladd A, Rescorla FJ, Billmire DF. Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Surgery 2008; 144: 540-545; discussion 545-547 [PMID: 18847637 DOI: 10.1016/j.surg.2008.07.005]
70. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753 [PMID: 16698746]
71. Riegler G, Tartaglione MT, Carratú R, D'Incá R, Valpiani D, Russo MI, Papi C, Fiorentini MT, Ingrosso M, Andreoli A, Vecchi M. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci 2000; 45: 462-465 [PMID: 10749318]
72. Solberg IC, Lygren I, Jahnsen J, Aadland E, Høie O, Cvancarova M, Bernklev T, Henriksen M, Sauar J, Vatn MH, Moum B. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009; 44: 431-440 [PMID: 19101844 DOI: 10.1080/00365520802600961]
73. Kalkan IH, Daʇli U, Oztaş E, Tunç B, Ulker A. Comparison of demographic and clinical characteristics of patients with early vs. adult vs. late onset ulcerative colitis. Eur J Intern Med 2013; 24: 273-277 [PMID: 23318090 DOI: 10.1016/j.ejim.2012.12.014]
74. Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, Vasseur F, Dupas JL, Cortot A, Dauchet L, Peyrin-Biroulet L, Lerebours E, Colombel JF, Gower-Rousseau C. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 2014; 63: 423-432 [PMID: 23408350]
75. Tremaine WJ, Timmons LJ, Loftus EV, Pardi DS, Sandborn WJ, Harmsen WS, Thapa P, Zinsmeister AR. Age at onset of inflammatory bowel disease and the risk of surgery for nonneoplastic bowel disease. Aliment Pharmacol Ther 2007; 25: 1435-1441 [PMID: 17539983]
76. Lee JH, Cheon JH, Moon CM, Park JJ, Hong SP, Kim TI, Kim WH. Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older? Digestion 2010; 81: 237-243 [PMID: 20110709 DOI: 10.1159/000253850]
77. Portela F, Magro F, Lago P, Cotter J, Cremers I, de Deus J, Vieira A, Lopes H, Caldeira P, Barros L, Reis J, Carvalho L, Gonçalves R, Campos MJ, Ministro P, Duarte MA, Amil J, Rodrigues S, Azevedo L, Costa-Pereira A. Ulcerative colitis in a Southern European country: a national perspective. Inflamm Bowel Dis 2010; 16: 822-829 [PMID: 19824069 DOI: 10.1002/ibd.21119]
78. Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturiratne A, Mufeena MN, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJ, Chan FK. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013; 145: 158-165. e2 [PMID: 23583432 DOI: 10.1053/j.gastro.2013.04.007]
79. Alkim C, Alkim H, Daʇli U, Parlak E, Ulker A, Sahi{dotless}n B. Extension of ulcerative colitis. Turk J Gastroenterol 2011; 22: 382-387 [PMID: 21948568]
80. Park SH, Kim YM, Yang SK, Kim SH, Byeon JS, Myung SJ, Cho YK, Yu CS, Choi KS, Chung JW, Kim B, Choi KD, Kim JH. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis 2007; 13: 278-283 [PMID: 17206722]
81. Kiss LS, Lakatos PL. Natural history of ulcerative colitis: current knowledge. Curr Drug Targets 2011; 12: 1390-1395 [PMID: 21466488]
82. Lee HJ, Jung ES, Lee JH, Hong SP, Kim TI, Kim WH, Cheon JH. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis. Hepatogastroenterology 2012; 59: 1415-1420 [PMID: 22683958 DOI: 10.5754/hge10680]
83. Lau A, Chande N, Ponich T, Gregor JC. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2008; 28: 606-613 [PMID: 18564323 DOI: 10.1111/j.1365-2036.2008.03772. x]
84. Breynaert C, Vermeire S, Rutgeerts P, Van Assche G. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk? Acta Gastroenterol Belg 2008; 71: 367-372 [PMID: 19317276]
85. Manninen P, Karvonen AL, Huhtala H, Aitola P, Hyöty M, Nieminen I, Hemminki H, Collin P. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. J Crohns Colitis 2013; 7: e551-e557 [PMID: 23619008 DOI: 10.1016/j.crohns.2013.04.003]
86. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012; 10: 639-645 [PMID: 22289873 DOI: 10.1016/j.cgh.2012.01.010]
87. Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, Beaugerie L, Gomollón F, Häuser W, Herrlinger K, Oldenburg B, Panes J, Portela F, Rogler G, Stein J, Tilg H, Travis S, Lindsay JO. Second European evidencebased consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013; 7: 1-33 [PMID: 23040453 DOI: 10.1016/j.crohns.2012.09.005]
88. Söderlund S, Brandt L, Lapidus A, Karlén P, Broström O, Löfberg R, Ekbom A, Askling J. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009; 136: 1561-1567; quiz 1818-1819 [PMID: 19422077]
89. Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 2012; 143: 382-389 [PMID: 22609382 DOI: 10.1053/j.gastro.2012.04.054]
90. Jess T, Simonsen J, Jørgensen KT, Pedersen BV, Nielsen NM, Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012; 143: 375-81.e1; quiz e13-4 [PMID: 22522090 DOI: 10.1053/j.gastro.2012.04.016]
91. Lennard-Jones JE, Ritchie JK, Hilder W, Spicer CC. Assessment of severity in colitis: a preliminary study. Gut 1975; 16: 579-584 [PMID: 1183857]
92. Carbonnel F, Gargouri D, Lémann M, Beaugerie L, Cattan S, Cosnes J, Gendre JP. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther 2000; 14: 273-279 [PMID: 10735919]
93. Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG, Jewell DP. Predicting outcome in severe ulcerative colitis. Gut 1996; 38: 905-910 [PMID: 8984031]
94. Carbonnel F, Lavergne A, Lémann M, Bitoun A, Valleur P, Hautefeuille P, Galian A, Modigliani R, Rambaud JC. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994; 39: 1550-1557 [PMID: 8026269]
95. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126: 451-459 [PMID: 14762782]
96. Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis 2008; 40: 547-553 [PMID: 18358796 DOI: 10.1016/j.dld.2008.01.017]
97. D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 2218-2224 [PMID: 22344983 DOI: 10.1002/ibd.22917]
98. Lamb CA, Mansfield JC. Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease. Frontline Gastroenterol 2011; 2: 13-18 [PMID: 23904968]
99. Gisbert JP, Bermejo F, Pérez-Calle JL, Taxonera C, Vera I, McNicholl AG, Algaba A, López P, López-Palacios N, Calvo M, González-Lama Y, Carneros JA, Velasco M, Maté J. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009; 15: 1190-1198 [PMID: 19291780 DOI: 10.1002/ibd.20933]
100. Lasson A, Simrén M, Stotzer PO, Isaksson S, Ohman L, Strid H. Fecal calprotectin levels predict the clinical course in patients with new onset of ulcerative colitis. Inflamm Bowel Dis 2013; 19: 576-581 [PMID: 23377170 DOI: 10.1097/MIB.0b013e31827e78be]
101. Ho GT, Lee HM, Brydon G, Ting T, Hare N, Drummond H, Shand AG, Bartolo DC, Wilson RG, Dunlop MG, Arnott ID, Satsangi J. Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. Am J Gastroenterol 2009; 104: 673-678 [PMID: 19262524 DOI: 10.1038/ajg.2008.119]
102. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993; 38: 1137-1146 [PMID: 8508710]
103. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year followup study. World J Gastroenterol 2003; 9: 2300-2307 [PMID: 14562397]
104. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, Tilloy E, Brazier F, Merle V, Dupas JL, Savoye G, Baldé M, Marti R, Lerebours E, Cortot A, Salomez JL, Turck D, Colombel JF. The natural history of pediatric ulcerative colitis: a populationbased cohort study. Am J Gastroenterol 2009; 104: 2080-2088 [PMID: 19436273 DOI: 10.1038/ajg.2009.177]
105. Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, Jewell DA, Sandborn WJ. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005; 54: 91-96 [PMID: 15591511]
106. Broomé U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis 2006; 26: 31-41 [PMID: 16496231]
107. Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, Seksik P. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol 2008; 14: 3497-3503 [PMID: 18567077]
108. Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002; 56: 48-54 [PMID: 12085034]
109. Kornfeld D, Ekbom A, Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 1997; 41: 522-525 [PMID: 9391253]
110. Prideaux L, De Cruz P, Ng SC, Kamm MA. Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 2012; 18: 1340-1355 [PMID: 22069240 DOI: 10.1002/ibd.21903]
111. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin Proc 1996; 71: 431-436 [PMID: 8628021]
112. Lombardi G, Annese V, Piepoli A, Bovio P, Latiano A, Napolitano G, Perri F, Conoscitore P, Andriulli A. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature. Dis Colon Rectum 2000; 43: 999-1007 [PMID: 10910250]
113. Ferrante M, Vermeire S, Katsanos KH, Noman M, Van Assche G, Schnitzler F, Arijs I, De Hertogh G, Hoffman I, Geboes JK, Rutgeerts P. Predictors of early response to infliximab in patients with ulcerative colitis. Inflamm Bowel Dis 2007; 13: 123-128 [PMID: 17206703]
114. Dubinsky MC, Mei L, Friedman M, Dhere T, Haritunians T, Hakonarson H, Kim C, Glessner J, Targan SR, McGovern DP, Taylor KD, Rotter JI. Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2010; 16: 1357-1366 [PMID: 20014019 DOI: 10.1002/ibd.21174]
115. Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Lakatos PL. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol 2008; 103: 665-681 [PMID: 18047543]
116. Barahona-Garrido J, Camacho-Escobedo J, García-Martínez CI, Tocay H, Cabiedes J, Yamamoto-Furusho JK. Antinuclear antibodies: a marker associated with steroid dependence in patients with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1039-1043 [PMID: 19107779 DOI: 10.1002/ibd.20852]